Enhancing sexual health in women with systemic lupus erythematosus (SLE): A mixed-methods systematic review of effective strategies
Authors:
- 12 November 2026
- journal article
- review article
- Published by SAGE Publications in Lupus
Abstract
Introduction: Sexual dysfunction is highly prevalent among women with systemic lupus erythematosus (SLE) and significantly impairs quality of life, intimate relationships, and psychological well-being. Despite its clinical relevance, sexual health is rarely addressed in routine rheumatology care, and evidence on effective interventions remains fragmented. Objectives: This mixed-methods systematic review aimed to evaluate the effectiveness of pharmacological and non-pharmacological interventions for improving sexual health outcomes in women with SLE while qualitatively synthesizing barriers and patient perspectives to inform multidisciplinary care. Methods: This review was conducted in accordance with PRISMA 2020 guidelines (PROSPERO ID: CRD420250652901). PubMed, Web of Science, Scopus, and ScienceDirect were searched for original studies published between 2000 and 2025. Eligible studies included randomized controlled trials and qualitative research evaluating sexual health interventions in women with SLE. Methodological quality was assessed using the Mixed Methods Appraisal Tool (MMAT, 2018). Due to heterogeneity in study populations, interventions, and outcome measures, findings were narratively synthesized. Results: Five studies met the inclusion criteria, comprising four randomized controlled trials (RCTs) and one qualitative descriptive study. Non-pharmacological interventions—including Extended Permission, Limited Information, Specific Suggestions, and Intensive Therapy (EX-PLISSIT)–based sexual counseling, supportive–expressive psychotherapy and patient education—consistently improved sexual function and intimacy. Pharmacological interventions demonstrated mixed effects: low-dose dehydroepiandrosterone (DHEA) was associated with improvements in sexual function and mental well-being, whereas transdermal testosterone patches showed no significant benefit. Inadequate communication and lack of routine sexual health assessment by rheumatologists were identified as major barriers to care. Conclusion: Sexual dysfunction in women with SLE is common yet underrecognized. Non-pharmacological interventions, particularly psychosexual counseling, appear effective and accessible, while pharmacological evidence remains inconclusive. Integrating sexual health into multidisciplinary rheumatology care through systematic screening, education, and interprofessional collaboration is essential.This publication has 27 references indexed in Scilit:
- Systemic lupus erythematosus and male reproductive health: A systematic review and meta-analysisAutoimmunity Reviews, 2025
- Current investigation of the high prevalence of sexual dysfunction in female patients with systemic lupus erythematosus: a cross-sectional studyRheumatology International, 2024
- Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional surveyRheumatology International, 2024
- The Effect of Sexual Counseling Based on EX‑PLISSIT Model on Improving the Sexual Function of Married Women with Systemic Lupus Erythematosus: A Randomized Controlled TrialSexuality and Disability, 2023
- Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic DiseasesAutoimmunity Reviews, 2022
- Treatment of Sexual Dysfunction in Women with Systemic Autoimmune Rheumatic Disorders: A Systematic ReviewSexual Medicine Reviews, 2022
- Biology of iatrogenic sexual dysfunction in men and women survivors of cancerUrologic Oncology: Seminars and Original Investigations, 2022
- Systemic Lupus Erythematosus (SLE) Therapy: The Old and the NewRheumatology and Therapy, 2020
- Sex Differences in Systemic Lupus ErythematosusMayo Clinic Proceedings, 2020
- Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosusAutoimmunity, 2005